Sucralfate: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Sucralfate. Educational only — not medical advice.
Labeled uses
INDICATIONS AND USAGE Sucralfate tablets, USP are indicated in: Short-term treatment (up to 8 weeks) of active duodenal ulcer. While healing with sucralfate may occur during the first week or two, treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by x-ray or endoscopic examination. Maintenance therapy for duodenal ulcer patients at reduced dosage after healing of acute ulcers.
Source: FDA labeling via NIH DailyMed (set b39f22c8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.